Cerebral metabolic change after treatment in biotinidase deficiency.

Abstract

A 13.5-year-old boy with biotinidase deficiency was studied 8 days before and 5 months after biotin treatment by positron emission tomography (PET) and computerized electroencephalographic topography (CET). With biotin treatment there was a marked improvement in the presenting symptom of loss of visual acuity and a more modest recovery in spastic quadraparesis. By PET scanning, the relative metabolic rate for glucose was more than 2 standard deviations lower in the temporal and occipital cortices than in adult or age-matched controls. With biotin treatment, these values rose to normal limits for both control groups. By CET, normalized EEG equivalent to the relative glucose metabolic rate showed asymmetric slowing in the left temporal and frontal regions before treatment, whereas none of the 32 leads exceeded normal limits of delta, theta, alpha or beta after treatment. These results suggest a strong correlation between clinical, metabolic and electrical measures of brain function as related to biotin treatment in biotinidase deficiency.

• Authors: I T Lott, S Lottenberg, W L Nyhan, M J Buchsbaum
• Journal: Journal of inherited metabolic disease (J Inherit Metab Dis) Vol. 16 Issue 2 Pg. 399-407 ( 1993) ISSN: 0141-8955 [Print] United States
• PMID: 8412000 (Publication Type: Case Reports, Journal Article)

Chemical References

• Fluorodeoxyglucose F18
• Biotin
• Deoxyglucose
• Amidohydrolases
• Biotinidase
• Glucose

Topics

• Adolescent
• Amidohydrolases (deficiency)
• Biotin (therapeutic use)
• Biotinidase
• Brain (diagnostic imaging, metabolism)
• Deoxyglucose (analogs & derivatives)
• Electroencephalography
• Fluorodeoxyglucose F18
• Glucose (metabolism)
• Humans
• Male
• Tomography, Emission-Computed